Amgen’s most recent trend suggests a bullish bias. One trading opportunity on Amgen is a Bull Put Spread using a strike $225.00 short put and a strike $220.00 long put offers a potential 31.23% return on risk over the next 21 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $225.00 by expiration. The full premium credit of $1.19 would be kept by the premium seller. The risk of $3.81 would be incurred if the stock dropped below the $220.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Amgen is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Amgen is bullish.
The RSI indicator is at 78.68 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Amgen
Amgen (AMGN) Gains As Market Dips: What You Should Know
Tue, 28 Dec 2021 23:00:11 +0000
Amgen (AMGN) closed at $225.77 in the latest trading session, marking a +0.27% move from the prior day.
Shares of Amgen Are Finally Beginning to Turn Around
Tue, 28 Dec 2021 13:14:00 +0000
Shares of Amgen Inc. has been weak for much of the past year but the charts are showing improvement. Let’s check out this pharmaceutical giant to see if we can take advantage of any further improvements.
GuidePath Growth and Income Fund Buys Schwab U.S. …
Tue, 28 Dec 2021 07:38:11 +0000
Investment company GuidePath Growth and Income Fund (Current Portfolio) buys Schwab U.S. Large-Cap ETF, Vanguard Real Estate Index Fund ETF, Comcast Corp, SPDR Bloomberg 1-3 Month T-Bill ETF, Progressive Corp, sells Vanguard High Dividend Yield Indx ETF, Vanguard International High Dividend Yield ETF, Global X MLP ETF, Raytheon Technologies Corp, Gilead Sciences Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, GuidePath Growth and Income Fund.
Ligand (LGND) Stock Surges 60% YTD: What’s Driving the Rally?
Mon, 27 Dec 2021 15:04:03 +0000
Strong demand for two of Ligand’s (LGND) partnered drugs, AMGN’s Krprolis and GILD’s Veklury, is driving its royalties. This is likely to continue next year.
AMGEN TO PRESENT AT THE GOLDMAN SACHS 14TH ANNUAL HEALTHCARE CEOS UNSCRIPTED CONFERENCE
Thu, 23 Dec 2021 21:00:00 +0000
Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference at 1:00 p.m. ET on Thursday, Jan. 6, 2022. Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference. Live audio of the conference call will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.
Follow Us on Facebook